Webinars

Choose Your Own Data Sharing Strategy: Leadership Edition

In this choose your own data sharing adventure, leaders were asked to navigate and overcome several twists and turns – in real time – to meet business needs, while balancing internal resistance to ...

Developing a Data-Sharing Leadership Playbook

Watch this on-demand executive roundtable presented by MIT Chief Data Officer & Information Quality program and Privacy Analytics – featuring a dynamic discussion about safely sharing sensitive ...

Gain the confidence to safely use and share sensitive data (with our advisory services)

Your organization’s sensitive data is a powerful and valuable resource. But using it in a way that fails to protect individual privacy under regulations such as GDPR, HIPAA, and CCPA can lead to ...

How Eclipse Trials Turns Your Clinical Trial Data into a Powerful Asset

Your structured clinical trial data is an increasingly valuable resource that benefits new analytics, research, and innovation. With the pressure being put on pharma to collaborate and share trial ...

3 Critical Data Anonymization Challenges Solved (with Eclipse Risk)

If you want to safely leverage the increasing value of your sensitive data by implementing data anonymization at scale, you’re likely facing one (or all) of these critical challenges:

How to Build a Data-Sharing Strategy for Pharma Innovation

Now more than ever, the eyes of the world are on sponsors to collaborate, sharing their clinical trial data to combat human health emergencies.

Kick-Start Your Clinical Trial Data Anonymization

In this brief webinar, Niamh McGuinness, Senior CTT Analyst, will be showcasing Privacy Analytics’ new Kick-Start service offer for clinical trial data anonymization.

Kick-Start Your Clinical Trial Document Anonymization

In this brief webinar, Niamh McGuinness, Senior CTT Analyst, will be showcasing Privacy Analytics’ new Kick-Start service offer for clinical trial document anonymization, which allows you to quickly ...

The Future of Clinical Document Submissions

As privacy concerns continue to make headlines in the pharmaceutical space, sponsors face growing pressure to meet ever stricter regulatory requirements to anonymize clinical trial document ...

Let's Talk Privacy, Interview with Luk Arbuckle

What are anonymization and de-identification? Do they mean the same thing? Is there even consensus about their meaning? Luk Arbuckle draws on his deep experience in anonymization to address these ...

Filter by Data Type

Categories